Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom

Autor: Albrecht, L. J., Höwner, A., Griewank, Klaus, Lueong, S. S., von Neuhoff, N., Horn, Peter A., Sucker, A., Paschen, Annette, Livingstone, Elisabeth, Ugurel, Selma, Zimmer, Lisa, Horn, S., Siveke, Jens T., Schadendorf, Dirk, Váraljai, R., Rösch, Alexander

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=unidue___bib::7d80bced745fe6d847a2752d2e7485de

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The predictive and prognostic significance of cell-free DNA concentration in melanoma.

Autor: Váraljai R; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Elouali S; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Lueong SS; Institute for Developmental Cancer Therapeutics & Division of Solid Tumor Translational Oncology (DKTK/DKFZ partner site Essen), West German Cancer Center University Hospital of Essen, Essen, Germany.; German Cancer Consortium and German Cancer Research Center (DKFZ), Heidelberg, Germany., Wistuba-Hamprecht K; Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany., Seremet T; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussel, Belgium., Siveke JT; Institute for Developmental Cancer Therapeutics & Division of Solid Tumor Translational Oncology (DKTK/DKFZ partner site Essen), West German Cancer Center University Hospital of Essen, Essen, Germany.; German Cancer Consortium and German Cancer Research Center (DKFZ), Heidelberg, Germany., Becker JC; Department of Translational Skin Cancer Research (TSCR), University Hospital of Essen, University of Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Sucker A; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Paschen A; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Horn PA; Institute for Transfusion Medicine, University Hospital of Essen, Essen, Germany., Neyns B; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussel, Belgium., Weide B; Department of Dermatology, University Medical Center Tübingen, Tübingen, Germany., Schadendorf D; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany., Roesch A; Department of Dermatology, University Hospital of Essen, University Duisburg-Essen and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen, Germany.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2021 Feb; Vol. 35 (2), pp. 387-395. Date of Electronic Publication: 2020 Jul 28.